Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer

References

• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. doi:10.1002/ijc.29210. PMID:25220842.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388(10060):2654–64. doi:10.1016/S0140-6736(16)30354-3. PMID:27156933.
   PubMed Web of Science ®Google Scholar
• Zayakin P, Ancans G, Silina K, Meistere I, Kalnina Z, Andrejeva D, Endzelins E, Ivanova L, Pismennaja A, Ruskule A, et al. Tumor-associated autoantibody signature for the early detection of gastric cancer. Int J Cancer. 2013;132(1):137–47. doi:10.1002/ijc.27667. PMID:22684876.
   PubMed Web of Science ®Google Scholar
• Rosati G, Ferrara D, Manzione L. New perspectives in the treatment of advanced or metastatic gastric cancer. World J Gastroenterol. 2009;15(22):2689–92. doi:10.3748/wjg.15.2689. PMID:19522017.
   PubMed Web of Science ®Google Scholar
• Yang L, Wang J, Li J, Zhang H, Guo S, Yan M, Zhu Z, Lan B, Ding Y, Xu M, et al. Identification of Serum biomarkers for gastric cancer diagnosis using a human proteome microarray. Mol Cell Proteomics. 2016;15(2):614–23. doi:10.1074/mcp.M115.051250. PMID:26598640.
   PubMed Web of Science ®Google Scholar
• Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–87. doi:10.1016/S1470-2045(08)70072-X. PMID:18308253.
   PubMed Web of Science ®Google Scholar
• Dan YY, So JB, Yeoh KG. Endoscopic screening for gastric cancer. Clin Gastroenterol Hepatol. 2006;4(6):709–16. doi:10.1016/j.cgh.2006.03.025. PMID:16765306.
   PubMed Web of Science ®Google Scholar
• Emoto S, Ishigami H, Yamashita H, Yamaguchi H, Kaisaki S, Kitayama J. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Gastric Cancer. 2012;15(2):154–61. doi:10.1007/s10120-011-0091-8. PMID:21892754.
   PubMed Web of Science ®Google Scholar
• Kim DH, Oh SJ, Oh CA, Choi MG, Noh JH, Sohn TS, Bae JM, Kim S. The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy. J Surg Oncol. 2011;104(6):585–91. doi:10.1002/jso.21919. PMID:21695697.
   PubMed Web of Science ®Google Scholar
• Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D, Zhang H. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. Bmc Cancer. 2017;17(1):737. doi:10.1186/s12885-017-3738-y. PMID:29121872.
   PubMedGoogle Scholar
• Tan EM, Zhang J. Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev. 2008;222(1):328–40. doi:10.1111/j.1600-065X.2008.00611.x. PMID:18364012.
   PubMedGoogle Scholar
• Liu W, Peng B, Lu Y, Xu W, Qian W, Zhang JY. Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis. Autoimmun Rev. 2011;10(6):331–5. doi:10.1016/j.autrev.2010.12.002. PMID:21167321.
   PubMed Web of Science ®Google Scholar
• Zhang JY, Tan EM. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn. 2010;10(3):321–8. doi:10.1586/erm.10.12. PMID:20370589.
   PubMed Web of Science ®Google Scholar
• Dai L, Li J, Tsay JJ, Yie TA, Munger JS, Pass H, Rom WN, Tan EM, Zhang JY. Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer. Oncoimmunology. 2017;6(5):e1310359. doi:10.1080/2162402X.2017.1310359. PMID:28638733.
   PubMed Web of Science ®Google Scholar
• Katchman BA, Chowell D, Wallstrom G, Vitonis AF, LaBaer J, Cramer DW, Anderson KS. Autoantibody biomarkers for the detection of serous ovarian cancer. Gynecol Oncol. 2017;146(1):129–36. doi:10.1016/j.ygyno.2017.04.005. PMID:28427776.
   PubMed Web of Science ®Google Scholar
• Tan HT, Low J, Lim SG, Chung MC. Serum autoantibodies as biomarkers for early cancer detection. Febs J. 2009;276(23):6880–904. doi:10.1111/j.1742-4658.2009.07396.x. PMID:19860826.
   PubMed Web of Science ®Google Scholar
• Zaenker P, Ziman MR. Serologic autoantibodies as diagnostic cancer biomarkers-a review. Cancer Epidemiol Biomarkers Prev. 2013;22(12):2161–81. doi:10.1158/1055-9965.EPI-13-0621. PMID:24057574.
   PubMed Web of Science ®Google Scholar
• Dai L, Tsay JC, Li J, Yie TA, Munger JS, Pass H, Rom WN, Zhang Y, Tan EM, Zhang JY. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Lung Cancer. 2016;99:172–9. doi:10.1016/j.lungcan.2016.07.018. PMID:27565936.
   PubMed Web of Science ®Google Scholar
• Zhang HF, Qin JJ, Ren PF, Shi JX, Xia JF, Ye H, Wang P, Song CH, Wang KJ, Zhang JY. A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer. Cancer Immunol Immunother. 2016;65(10):1233–42. doi:10.1007/s00262-016-1886-6. PMID:27553002.
   PubMed Web of Science ®Google Scholar
• Kruse JP, Gu W. Modes of p53 regulation. Cell. 2009;137(4):609–22. doi:10.1016/j.cell.2009.04.050. PMID:19450511.
   PubMed Web of Science ®Google Scholar
• Muller PAJ, Vousden KH. p53 mutations in cancer. Nat Cell Biol. 2013;15(1):2–8. doi:10.1038/ncb2641. PMID:23263379.
   PubMed Web of Science ®Google Scholar
• Gong L, Govan JM, Evans EB, Dai H, Wang E, Lee S, Lin H, Lazar AJ, Mills GB, Lin S. Nuclear PTEN tumor-suppressor functions through maintaining heterochromatin structure. Cell Cycle. 2015;14(14):2323–32. doi:10.1080/15384101.2015.1044174. PMID:25946202.
   PubMed Web of Science ®Google Scholar
• Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, Yin Y. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell. 2007;128(1):157–70. doi:10.1016/j.cell.2006.11.042. PMID:17218262.
   PubMed Web of Science ®Google Scholar
• Bell JL, Wachter K, Muhleck B, Pazaitis N, Kohn M, Lederer M, Huttelmaier S. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci. 2013;70(15):2657–75. doi:10.1007/s00018-012-1186-z. PMID:23069990.
   PubMed Web of Science ®Google Scholar
• Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol. 1999;19(2):1262–70. doi:10.1128/MCB.19.2.1262. PMID:9891060.
   PubMed Web of Science ®Google Scholar
• Bell JL, Wachter K, Muhleck B, Pazaitis N, Kohn M, Lederer M, Huttelmaier S. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci. 2013;70(15):2657–75. doi:10.1007/s00018-012-1186-z. PMID:23069990.
   PubMed Web of Science ®Google Scholar
• Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1999;19(1):1–11. doi:10.1128/MCB.19.1.1. PMID:9858526.
   PubMed Web of Science ®Google Scholar
• Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22–35. doi:10.1016/j.cell.2012.03.003. PMID:22464321.
   PubMed Web of Science ®Google Scholar
• Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int J Cancer. 2012;130(8):1715–25. doi:10.1002/ijc.27316. PMID:22025288.
   PubMed Web of Science ®Google Scholar
• Joshi S, Yang J, Wang Q, Li P, Wang H, Zhang Q, Xiong Y, Pickering BF, Parker-Thornburg J, Behringer RR, et al. 14-3-3zeta loss impedes oncogene-induced mammary tumorigenesis and metastasis by attenuating oncogenic signaling. Am J Cancer Res. 2017;7(8):1654–64. PMID:28861322.
   PubMed Web of Science ®Google Scholar
• Grisendi S, Mecucci C, Falini B, Pandolfi PP. Nucleophosmin and cancer. Nat Rev Cancer. 2006;6(7):493–505. doi:10.1038/nrc1885. PMID:16794633.
   PubMed Web of Science ®Google Scholar
• Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell. 2004;119(5):591–602. doi:10.1016/j.cell.2004.11.022. PMID:15550242.
   PubMed Web of Science ®Google Scholar
• DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45. doi:10.2307/2531595. PMID:3203132.
   PubMed Web of Science ®Google Scholar
• Fortner RT, Damms-Machado A, Kaaks R. Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection. Gynecol Oncol. 2017;147(2):465–80. doi:10.1016/j.ygyno.2017.07.138. PMID:28800944.
   PubMed Web of Science ®Google Scholar
• Broodman I, Lindemans J, van Sten J, Bischoff R, Luider T. Serum protein markers for the early detection of lung cancer: A focus on autoantibodies. J Proteome Res. 2017;16(1):3–13. doi:10.1021/acs.jproteome.6b00559. PMID:27769114.
   PubMed Web of Science ®Google Scholar
• Dai L, Ren P, Liu M, Imai H, Tan EM, Zhang JY. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Clin Immunol. 2014;152(1-2):127–39. doi:10.1016/j.clim.2014.03.007. PMID:24667685.
   PubMed Web of Science ®Google Scholar
• Fujiwara S, Wada H, Kawada J, Kawabata R, Takahashi T, Fujita J, Hirao T, Shibata K, Makari Y, Iijima S, et al. NY-ESO-1 antibody as a novel tumour marker of gastric cancer. Br J Cancer. 2013;108(5):1119–25. doi:10.1038/bjc.2013.51. PMID:23403818.
   PubMed Web of Science ®Google Scholar
• Werner S, Chen H, Butt J, Michel A, Knebel P, Holleczek B, Zornig I, Eichmuller SB, Jager D, Pawlita M, et al. Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer. Sci Rep. 2016;6:25467. doi:10.1038/srep25467. PMID:27140836.
   PubMed Web of Science ®Google Scholar
• Tsunemi S, Nakanishi T, Fujita Y, Bouras G, Miyamoto Y, Miyamoto A, Nomura E, Takubo T, Tanigawa N. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer. Oncol Rep. 2010;23(4):949–56. doi:10.3892/or_00000719. PMID:20204278.
   PubMed Web of Science ®Google Scholar
• Zhang JY. Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma. Autoimmun Rev. 2007;6(3):143–8. doi:10.1016/j.autrev.2006.09.009. PMID:17289549.
   PubMed Web of Science ®Google Scholar
• Katchman BA, Chowell D, Wallstrom G, Vitonis AF, LaBaer J, Cramer DW, Anderson KS. Autoantibody biomarkers for the detection of serous ovarian cancer. Gynecol Oncol. 2017;146(1):129–36. doi:10.1016/j.ygyno.2017.04.005. PMID:28427776.
   PubMed Web of Science ®Google Scholar
• Barderas R, Babel I, Diaz-Uriarte R, Moreno V, Suarez A, Bonilla F, Villar-Vazquez R, Capella G, Casal JI. An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays. J Proteomics. 2012;75(15):4647–55. doi:10.1016/j.jprot.2012.03.004. PMID:22465712.
   PubMed Web of Science ®Google Scholar
• Hoshino I, Nagata M, Takiguchi N, Nabeya Y, Ikeda A, Yokoi S, Kuwajima A, Tagawa M, Matsushita K, Satoshi Y, et al. Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer. Cancer Sci. 2017;108(3):308–15. doi:10.1111/cas.13158. PMID:28064445.
   PubMed Web of Science ®Google Scholar
• Werner S, Chen H, Tao S, Brenner H. Systematic review: serum autoantibodies in the early detection of gastric cancer. Int J Cancer. 2015;136(10):2243–52. doi:10.1002/ijc.28807. PMID:24615018.
   PubMed Web of Science ®Google Scholar
• Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93(14):1054–61. doi:10.1093/jnci/93.14.1054. PMID:11459866.
   PubMed Web of Science ®Google Scholar
• Dai L, Li J, Xing M, Sanchez TW, Casiano CA, Zhang JY. Using Serological proteome analysis to identify Serum Anti-Nucleophosmin 1 autoantibody as a potential biomarker in European-American and African-American patients with prostate cancer. Prostate. 2016;76(15):1375–86. doi:10.1002/pros.23217. PMID:27418398.
   PubMed Web of Science ®Google Scholar
• Danna EA, Sinha P, Gilbert M, Clements VK, Pulaski BA, Ostrand-Rosenberg S. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res. 2004;64(6):2205–11. doi:10.1158/0008-5472.CAN-03-2646. PMID:15026364.
   PubMed Web of Science ®Google Scholar